Alberto Gil-Jimenez

576 citations
6 papers · 107 indexed · h-index 5
Topics
Bladder and Urothelial Cancer Treatments (5 papers)Cancer Immunotherapy and Biomarkers (3 papers)Urinary and Genital Oncology Studies (3 papers)

In The Last Decade

Alberto Gil-Jimenez

6 papers receiving 107 citations

Peers

Alberto Gil-Jimenez
Comparison fields: 5 of 21
  • Surgery 74
  • Oncology 48
  • Immunology 29
  • Pulmonary and Respiratory Medicine 16
  • Rheumatology 16
Replace Yuanyuan Bao with:
Yuanyuan Bao China
William Carlos Nahas Brazil
Inmaculada Lasa Spain
Eugenio Morandi Italy
Iris M. Seignette Netherlands
Mingzhe Xiao China
Jianzhong Wang China
Sophie Fuerst Germany
Olivier Mauvais France
Olamide Olawoyin United States
Alberto Gil-Jimenez relative to Yuanyuan Bao China Yuanyuan Bao's profile →
Citations per field
00.5×
Yuanyuan Bao · 1×
Citations per year

Countries citing papers authored by Alberto Gil-Jimenez

Since Specialization
Citations

This map shows the geographic impact of Alberto Gil-Jimenez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Gil-Jimenez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Gil-Jimenez more than expected).

Fields of papers citing papers by Alberto Gil-Jimenez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Gil-Jimenez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Gil-Jimenez. The network helps show where Alberto Gil-Jimenez may publish in the future.

Co-authorship network of co-authors of Alberto Gil-Jimenez

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Gil-Jimenez. A scholar is included among the top collaborators of Alberto Gil-Jimenez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Gil-Jimenez. Alberto Gil-Jimenez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 10
2 3
3 6
4 34
5 26
6 28

About Alberto Gil-Jimenez

Alberto Gil-Jimenez is a scholar working on Urology, Oncology and Surgery, having authored 6 papers that have together received 107 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Urinary and Genital Oncology Studies (3 papers). The work is most often cited by research in Oncology (48 citations), Surgery (74 citations) and Immunology (29 citations). Alberto Gil-Jimenez has collaborated with scholars based in Netherlands, Germany and Switzerland. Frequent co-authors include Michiel S. van der Heijden, Annegien Broeks, Lodewyk F.A. Wessels, Daniël J. Vis, Dennis Peters, Bas W.G. van Rhijn, Erik Hooijberg, Maurits L. van Montfoort, Karīna Siliņa and Charlotte S. Voskuilen. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026